Peptides presented by DNA-specific B lymphocytes in lupus

狼疮中 DNA 特异性 B 淋巴细胞呈递的肽

基本信息

项目摘要

DESCRIPTION (provided by applicant): This grant proposal aims to identify the peptides that mediate T cell help for dsDNA-specific B lymphocytes in lupus. Systemic lupus erythematosus (SLE) is a disease of unknown etiology. Female (NZB x NZW) F1 (abbreviated B/W) mice recapitulate most of the salient characteristics of human lupus patients. Among these characteristics are serum antibodies to dsDNA, which are specific for the clinical diagnosis in a majority of SLE patients, as well as in all older B/W mice. An important question, therefore, is what drives production of high-affinity anti-dsDNA antibody? In the B/W mouse, the generation of high-affinity anti-dsDNA antibodies of IgG class is absolutely T-helper- cell dependent. dsDNA by itself is not an antigen in either normal or B/W mice, and DNA is not bound and presented by MHC molecules to T helper cells. The prevailing hypothesis is that DNA-protein complexes such as nucleosomes mediate the generation of high-affinity IgG antibodies. But the identity of the physiological B cell antigen is unknown. Specifically, there are no peptides known that are presented by dsDNA-specific B cells from any lupus-prone mouse model. As a result, it is not known how T cells help induce high-affinity anti-dsDNA antibodies. To reduce the complexity of the autoimmune response, we will make use of a classic lupus mouse model that has been modified by transgenesis in a conceptually simple way. It yields a quasimonoclonal auto- immune response to (only) dsDNA, while leaving the kinetics of the response intact. Unlike the germinal center B cells in old wild-type B/W mice, with various antigenic specificities, the majority of the B cells of the old transgenic mice have identical and monoclonal dsDNA specificity with high affinity. We will sort the germinal center B cells, and elute and identify th peptides bound to their class II molecules. We will then test these peptides for their ability to stimulate T cells of the B/W mice and for their function in the production of anti-dsDNA antibody. This will indicate which antigen is internalized by the immunoglobulin receptor of B cells with high affinity to dsDNA.
描述(由申请人提供):本拨款提案旨在鉴定介导狼疮中 dsDNA 特异性 B 淋巴细胞 T 细胞帮助的肽。系统性红斑狼疮(SLE)是一种病因不明的疾病。雌性 (NZB x NZW) F1(缩写 B/W)小鼠概括了人类狼疮患者的大部分显着特征。这些特征包括双链 DNA 的血清抗体,它对于大多数 SLE 患者以及所有老年 B/W 小鼠的临床诊断具有特异性。因此,一个重要的问题是,是什么驱动高亲和力抗 dsDNA 抗体的产生?在 B/W 小鼠中,IgG 类高亲和力抗 dsDNA 抗体的产生绝对依赖于 T 辅助细胞。在正常小鼠或 B/W 小鼠中,dsDNA 本身并不是抗原,并且 DNA 不会与 MHC 分子结合并呈递给 T 辅助细胞。普遍的假设是 DNA-蛋白质复合物(例如核小体)介导高亲和力 IgG 抗体的产生。但生理 B 细胞抗原的身份尚不清楚。具体而言,尚无已知的肽由任何狼疮易发小鼠模型的 dsDNA 特异性 B 细胞呈递。因此,尚不清楚 T 细胞如何帮助诱导高亲和力抗 dsDNA 抗体。为了降低自身免疫反应的复杂性,我们将利用经典的狼疮小鼠模型,该模型已通过转基因以概念上简单的方式进行了修改。它产生针对(仅)dsDNA 的准单克隆自身免疫反应,同时保持反应动力学完整。与老野生型B/W小鼠的生发中心B细胞不同,具有多种抗原特异性, 老转基因小鼠的大多数B细胞具有相同的单克隆dsDNA特异性,具有高亲和力。我们将对生发中心 B 细胞进行分类,并洗脱并鉴定与其 II 类分子结合的肽。然后我们将测试这些肽刺激 B/W 小鼠 T 细胞的能力以及它们在产生抗 dsDNA 抗体中的功能。这将表明哪种抗原被与 dsDNA 具有高亲和力的 B 细胞的免疫球蛋白受体内化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATTHIAS R WABL其他文献

MATTHIAS R WABL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATTHIAS R WABL', 18)}}的其他基金

Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    8088482
  • 财政年份:
    2010
  • 资助金额:
    $ 17.44万
  • 项目类别:
Tumor Suppressors in Lymphocytes
淋巴细胞中的肿瘤抑制因子
  • 批准号:
    7027215
  • 财政年份:
    2006
  • 资助金额:
    $ 17.44万
  • 项目类别:
Tumor Suppressors in Lymphocytes
淋巴细胞中的肿瘤抑制因子
  • 批准号:
    7325816
  • 财政年份:
    2006
  • 资助金额:
    $ 17.44万
  • 项目类别:
Tumor Suppressors in Lymphocytes
淋巴细胞中的肿瘤抑制因子
  • 批准号:
    7231727
  • 财政年份:
    2006
  • 资助金额:
    $ 17.44万
  • 项目类别:
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEM
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    6373658
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:
Gene Targeted Mice With A Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    7406815
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    8465786
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    8278599
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    8663161
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
  • 批准号:
    8077966
  • 财政年份:
    1998
  • 资助金额:
    $ 17.44万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 17.44万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 17.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了